INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 222 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $576,000 | +225.4% | 65,037 | +325.1% | 0.00% | – |
Q3 2020 | $177,000 | -58.7% | 15,300 | -3.8% | 0.00% | -100.0% |
Q2 2020 | $429,000 | +240.5% | 15,900 | -29.6% | 0.00% | – |
Q3 2018 | $126,000 | +193.0% | 22,600 | +105.5% | 0.00% | – |
Q2 2018 | $43,000 | -17.3% | 11,000 | 0.0% | 0.00% | – |
Q1 2018 | $52,000 | +30.0% | 11,000 | +13.4% | 0.00% | – |
Q4 2017 | $40,000 | – | 9,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
Beck Bode, LLC | 41,218 | $33,799 | 0.01% |